Portland, OR -- (SBWire) -- 06/29/2017 --Protein engineering can be defined as the modification of protein structure with recombinant DNA technology or chemical treatment to serve a desirable function and better use in medicine, industry and agriculture. Preference for protein-based drugs to non-protein-based ones along with reduced overall timeline and lower cost for drug discovery are the factors that are likely to drive the protein engineering market. High prevalence rate of lifestyle diseases along growth in funding for protein engineering. High cost of tools and instruments used in protein engineering techniques are the factors that drive the growth of the market. The demand of protein engineering developing countries coupled with preference of protein therapy over gene therapy along with the expiry of blockbuster biologics drugs in the near future. Lack of qualified researchers are the factors that offer abundant growth opportunities in the market.
Get full summary of the Report: https://www.alliedmarketresearch.com/protein-engineering-market
The report segments the market on the basis of products, technology, protein type, end-user, and geography. On the basis of products, the report segments the market into instruments, reagents and services and software. On the basis of technology, this market is segmented into rational protein design and irrational protein design. Based on protein type, the market is segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others which include interleukins, follicle stimulating hormones, enzyme replacement. On the basis of end-users the market is segmented into academic research institutes, pharmaceutical & biotechnology companies and contract research organizations. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Get sample of the Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1129
KEY MARKET SEGMENTS:
By Product
Instruments
Reagents
Services & Software
By Technology
Rational Protein Design
Irrational Protein Design
By Protein Type
Monoclonal Antibodies
Insulin
Erythropoietin
Interferon
Colony Stimulating Factor
Growth Hormones
Coagulation Factor
Vaccines
Others
By End User
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
By Region
North America
Europe
Asia-Pacific
LAMEA
Key Company Profile
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
Danaher Corporation
General Electric
Perkinelmer, Inc.
Genscripts USA, Inc
Sigma-Aldrich Corporation
Thermo Fisher Scientific
Waters Corporation
Global Protein Engineering Market - Opportunities and Forecasts, 2016 - 2022